Tolperisone
From Wikipedia, the free encyclopedia
Tolperisone
|
|
Systematic (IUPAC) name | |
2-methyl-1-(4-methylphenyl)-3-(1-piperidyl)propan-1-one | |
Identifiers | |
CAS number | |
ATC code | M03 |
PubChem | |
Chemical data | |
Formula | C16H23NO |
Mol. mass | 245.36 g/mol |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Tolperisone, a piperidine derivative, is a centrally acting muscle relaxant. Brand names include Mydocalm and Mydeton.
[edit] External links
- Hofer D, Lohberger B, Steinecker B, Schmidt K, Quasthoff S, Schreibmayer W (2006). "A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms.". Eur J Pharmacol 538 (1-3): 5–14. doi: . PMID 16650844.
- Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S, Gere A, Csejtei M, Tarnawa I (2005). "Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels.". J Pharmacol Exp Ther 315 (3): 1237–46. doi: . PMID 16126840.
- Ribi C, Vermeulen C, Hauser C (2003). "Anaphylactic reactions to tolperisone (Mydocalm).". Swiss Med Wkly 133 (25-26): 369–71. PMID 12947534.
|